Skip to content

Insider · CIK 0001365369

John F Sheridan

ceopresidentofficerdirector

Files at TNDM (TANDEM DIABETES CARE INC). First filing Aug 11, 2025, latest Aug 11, 2025.

In brief

John F Sheridan files SEC Form 4 as CEO, president and director at TNDM (TANDEM DIABETES CARE INC). Since Aug 11, 2025, John F Sheridan has reported 1 open-market buy worth $102k and 0 open-market sells worth $0, the latest filed on Aug 11, 2025.

A track record needs three past buys with six months of prices behind them; John F Sheridan has 0, so none is measured yet.

The newest scored trade: bought $102k of TNDM on Aug 11, 2025, filed Aug 11, 2025, scored 64 (notable).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$102k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TNDM: TANDEM DIABETES CARE INC

TNDMOct 9, 2026 · close 16.11

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
64Notable
TNDMbuy 2
TANDEM DIABETES CARE INC
$102k
10,000 shares
+10%0% from low-78% from high

Transactions

The newest 50 of 95 rows this insider has filed.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,982$0.00$0158,425Aug 18, 2026
Aug 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-3,044$22.72$69k155,381Aug 18, 2026
Aug 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+9,934$0.00$0165,315Aug 18, 2026
Aug 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-5,055$22.72$115k160,260Aug 18, 2026
Aug 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,982$0.00$017,947Aug 18, 2026
Aug 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-9,934$0.00$069,537Aug 18, 2026
May 29, 2026TNDM
TANDEM DIABETES CARE INC
AGrant or award
Restricted Stock Unitderivative
+191,103$0.00$0191,103Jun 2, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,472$0.00$0130,163May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-2,785$12.82$36k127,378May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,982$0.00$0133,360May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-3,044$12.82$39k130,316May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+39,735$0.00$0170,051May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-18,944$12.82$243k151,107May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
AGrant or award
Common Stock
+1,336$10.90$15k152,443May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,472$0.00$00May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,982$0.00$023,929May 19, 2026
May 15, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-39,735$0.00$079,471May 19, 2026
Feb 17, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,471$0.00$0123,071Feb 19, 2026
Feb 17, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-1,963$18.95$37k121,108Feb 19, 2026
Feb 17, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,983$0.00$0127,091Feb 19, 2026
Feb 17, 2026TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-2,400$18.95$45k124,691Feb 19, 2026
Feb 17, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,471$0.00$05,472Feb 19, 2026
Feb 17, 2026TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,983$0.00$029,911Feb 19, 2026
Nov 17, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,472$0.00$0117,435Nov 19, 2025
Nov 17, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-2,779$18.61$52k114,656Nov 19, 2025
Nov 17, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,982$0.00$0120,638Nov 19, 2025
Nov 17, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-3,038$18.61$57k117,600Nov 19, 2025
Nov 17, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,472$0.00$010,943Nov 19, 2025
Nov 17, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,982$0.00$035,894Nov 19, 2025
Aug 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,471$0.00$0111,798Aug 19, 2025
Aug 15, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-2,779$10.82$30k109,019Aug 19, 2025
Aug 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,982$0.00$0115,001Aug 19, 2025
Aug 15, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-3,038$10.82$33k111,963Aug 19, 2025
Aug 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,471$0.00$016,415Aug 19, 2025
Aug 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,982$0.00$041,876Aug 19, 2025
Aug 11, 2025TNDM
TANDEM DIABETES CARE INC
POpen-market purchase
Common Stock
+10,000$10.23$102k106,327Aug 11, 2025
May 30, 2025TNDM
TANDEM DIABETES CARE INC
AGrant or award
Performance Stock Unitderivative
+119,204$0.00$0119,204Jun 5, 2025
May 30, 2025TNDM
TANDEM DIABETES CARE INC
AGrant or award
Restricted Stock Unitderivative
+119,206$0.00$0119,206Jun 5, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
AGrant or award
Common Stock
+1,359$15.64$21k80,368May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+792$0.00$081,160May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-403$22.70$9,14880,757May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+2,236$0.00$082,993May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-1,136$22.70$26k81,857May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+5,472$22.70$124k87,329May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-2,779$22.70$63k84,550May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Common Stock
+23,929$0.00$0108,479May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
FTax withholding
Common Stock
-12,152$22.70$276k96,327May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-792$0.00$00May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-2,236$0.00$00May 19, 2025
May 15, 2025TNDM
TANDEM DIABETES CARE INC
MOption exercise
Restricted Stock Unitderivative
-5,472$0.00$021,886May 19, 2025
50 of 95 rows shown.

Questions about John F Sheridan

Answered from the filings on this page, as of the latest one.

Is John F Sheridan buying or selling?

Not in the last 12 months. John F Sheridan's latest open-market trade on SEC Form 4 was bought $102k of TNDM on Aug 11, 2025.

How did John F Sheridan's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John F Sheridan has 0.

Where does John F Sheridan file Form 4?

John F Sheridan has filed Form 4 at TNDM (TANDEM DIABETES CARE INC) as PRESIDENT & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.